Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis

L. Guillot, G. Thouvenin, F. Flamein, C. Caillaud, K. Chadelat, C. Charlier, J. Beucher, H. Corvol, A. Clement, R. Epaud (Paris, France)

Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Session: Biomarkers in diffuse parenchymal lung disease
Session type: E-Communication Session
Number: 5668
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Guillot, G. Thouvenin, F. Flamein, C. Caillaud, K. Chadelat, C. Charlier, J. Beucher, H. Corvol, A. Clement, R. Epaud (Paris, France). Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 5668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
Source: Eur Respir J 2001; 17: 716-722
Year: 2001



Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007

Elastase and α1-proteinase inhibitor in bronchoalveolar lavage fluid of children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

Activity of proteinase-inhibitor enzymes and secretory sIg A of patients with chronic obctructive pulmonary disease in bronchoalveolar lavage fluid
Source: Annual Congress 2006 - Implications of progressive airway obstruction
Year: 2006

Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015

The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012



The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

SP-A and blastase in BAL during mechanicalventiration
Source: Eur Respir J 2004; 24: Suppl. 48, 204s
Year: 2004

Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006

Altered expression of bronchoalveolar lavage fluid proteins in sarcoidosis: A proteomics approach
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003

ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002